MeSH tree: D12.776.124
Scientists have long sought to understand why some people with no known risk factors develop cancer while others with significant risk never do. The answer may lie in immune proteins known as autoantibodies (auto-Abs), suggests ...
Jul 25, 2026
0
12
Viral infections that attack the lungs are among the leading reasons infants are hospitalized. A new treatment may offer protection against these infections that is as effective and safe as existing options but requires far ...
Do you know your blood type? It is important information used for blood transfusions, but few realize that blood types could also be linked to disease risks. In the general population, people with blood type O have been reported ...
Jul 21, 2026
0
3
Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune "brakes" exploited by tumors to evade attack—show limited efficacy in some brain tumors. A KAIST research team ...
Jul 20, 2026
0
15
Although the COVID-19 pandemic has largely subsided, scientists continue to investigate why the virus proved so deadly, causing at least 3 million deaths worldwide, according to the latest estimates by the World Health Organization ...
Jul 20, 2026
0
8
Using advanced electron microscopy, researchers in Leiden have captured detailed images showing how, in the rare pregnancy disorder FNAIT, antibodies produced by the mother can cause bleeding in fetuses. The findings, published ...
Jul 20, 2026
0
4
Pulmonary fibrosis is a deadly disease in which scar tissue grows in the lungs, making breathing more difficult. Approximately 2,170 Australians are diagnosed annually with idiopathic pulmonary fibrosis (IPF), a form of the ...
Jul 16, 2026
0
13
Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary liver cancer called hepatocellular ...
Jul 15, 2026
0
8
A study led by researchers at Open Targets, EMBL's European Bioinformatics Institute (EMBL-EBI), the University of Cambridge and others has identified a set of plasma proteins that could be used to diagnose and monitor patients ...
Jul 15, 2026
0
4
An international team led by the Josep Carreras Leukaemia Research Institute (IJC) in Barcelona, the Centre for Genomics and Oncological Research (GENyO) and the University of Granada (UGR) has identified a new biological ...
Jul 14, 2026
0
4
